2021
DOI: 10.1007/s11033-021-06267-3
|View full text |Cite
|
Sign up to set email alerts
|

Chlorogenic acid inhibits proliferation in human hepatoma cells by suppressing noncanonical NF-κB signaling pathway and triggering mitochondrial apoptosis

Abstract: Chlorogenic acid (CGA), a phenylpropanoid derived from Eucommia ulmoides Oliver, has been shown to exhibit potent cytotoxic and anti-proliferative activities against several human cancers. However, the effects of CGA on hepatocellular carcinoma (HCC) and the underlying mechanisms have not been intensively studied. In this study, the CGA treatment effects on the viability of human hepatoma cells were investigated by MTT assay. Our data showed that CGA could dose-dependently inhibit the activity of human hepatom… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
18
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(19 citation statements)
references
References 46 publications
(73 reference statements)
1
18
0
Order By: Relevance
“…These compounds might partly contribute to the antioxidant activity of Akebia trifoliate peel extract. Chlorogenic acid was one of the most abundant polyphenols in many natural products and exhibited antioxidant, anti-inflammatory as well as anticancer effects (such as anti-metastatic effects and anti-proliferative activity) [ 26 , 27 , 28 , 29 ]. Besides, clinical studies indicated that chlorogenic acid could decrease the risk of metabolic syndromes and chronic diseases (cardiovascular diseases, neurodegenerative diseases and liver diseases).…”
Section: Resultsmentioning
confidence: 99%
“…These compounds might partly contribute to the antioxidant activity of Akebia trifoliate peel extract. Chlorogenic acid was one of the most abundant polyphenols in many natural products and exhibited antioxidant, anti-inflammatory as well as anticancer effects (such as anti-metastatic effects and anti-proliferative activity) [ 26 , 27 , 28 , 29 ]. Besides, clinical studies indicated that chlorogenic acid could decrease the risk of metabolic syndromes and chronic diseases (cardiovascular diseases, neurodegenerative diseases and liver diseases).…”
Section: Resultsmentioning
confidence: 99%
“…Attenuating mitochondrial membrane potential and reciprocally modulating Bcl-2 and Bax, CGA promotes programmed cell death in A498 human kidney cancer cells, for instance [21]. Moreover, the involvement of the Bax/Bcl-2 pathway has latterly been documented in CGA-mediated apoptosis induction in lung, breast, and hepatoma cancer cells [36,56,57]. Intriguingly, in the only existing study in which CGA potentiates Doxo-mediated cytotoxic effects, Elrazik and colleagues documented a simultaneous engagement of both intrinsic and extrinsic related pathways [26].…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, even though an initial CGA Phase I clinical trial has recently been concluded, demonstrating that its injection is safe and well-tolerated in recurrent high grade glioma patients, collecting safety data in a larger statistical sample is absolutely necessary to define the tolerance and pharmacokinetics of this compound (NCT02245204). Limited studies have been conducted even in preclinical models, and thus additional insights must be provided aimed at defining the CGA impact on both cancer and healthy tissues [37,57]. In this respect, we previously addressed the colony-forming ability in both OS and non-tumor mouse embryonic fibroblasts NIH 3T3 [23].…”
Section: Discussionmentioning
confidence: 99%
“…Anti-tumor ↓Anti-apoptotic gene Bcl-2/Bcl-XL ↑Pro-apoptotic gene Bax/Bcl-XS/Bad (34,35) ↑p38 mitogen-activated protein kinase (p38 MAPK) ↑c-Jun N-terminal Kinase (JNK) ↓Stem cell marker genes Nanog, POU5F1, Sox2, CD44, Oct4…”
Section: Biological Activity Mechanism Of Action Referencesmentioning
confidence: 99%